Cargando…

Mediterranean Diet, Energy Restriction, Physical Activity, and Atherogenicity of Very‐Low Density Lipoproteins: Findings from Two Randomized Controlled Trials

SCOPE: Some very‐low density lipoprotein (VLDL) properties may render them more pro‐atherogenic. We aimed to assess whether a Mediterranean diet (MedDiet) or an energy‐reduced MedDiet with increased physical activity improves them. METHODS AND RESULTS: In a sample of the PREvención con DIeta MEDiter...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez‐Vega, Karla Alejandra, Castañer, Olga, Sanllorente, Albert, Lassale, Camille, Ros, Emilio, Pintó, Xavier, Estruch, Ramón, Salas‐Salvadó, Jordi, Corella, Dolores, Alonso‐Gómez, Ángel M., Serra‐Majem, Lluis, Razquin, Cristina, Fiol, Miquel, Lapetra, José, Gómez‐Gracia, Enrique, Tinahones, Francisco J., Hernáez, Álvaro, Fitó, Montserrat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078255/
https://www.ncbi.nlm.nih.gov/pubmed/36353918
http://dx.doi.org/10.1002/mnfr.202200338
Descripción
Sumario:SCOPE: Some very‐low density lipoprotein (VLDL) properties may render them more pro‐atherogenic. We aimed to assess whether a Mediterranean diet (MedDiet) or an energy‐reduced MedDiet with increased physical activity improves them. METHODS AND RESULTS: In a sample of the PREvención con DIeta MEDiterránea (PREDIMED) study, a 1‐year intervention with MedDiet with extra‐virgin olive oil (n = 89) or nuts (MedDiet‐Nuts; n = 79) is compared with a low‐fat diet (n = 90). In the PREDIMED‐Plus study, a 1‐year intervention with energy‐reduced MedDiet and physical activity (n = 103) is compared with an ad libitum MedDiet (n = 101). VLDL levels of apolipoprotein C‐I, C‐III, triglycerides, and cholesterol; the apolipoprotein E‐/C‐I ratio; and VLDL ex‐vivo triglyceride transfer are measured. In PREDIMED participants in both MedDiet groups combined, VLDL apolipoprotein C‐III levels are nominally reduced (−0.023 SD units, 95% CI −0.44 to −0.014, p = 0.037). VLDL triglyceride transfer is nominally increased in the MedDiet‐Nuts group (+0.39 SD units, 95% CI 0.012–0.78, p = 0.045). In PREDIMED‐Plus, no inter‐group differences are detected. CONCLUSIONS: In older adults at high cardiovascular risk, MedDiet is associated with lower VLDL atherogenicity versus a low‐fat diet. No differences are seen after an energy‐reduced MedDiet with physical activity.